Imidazopyrazines as protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/498 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2628455

In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions.

La présente invention concerne une nouvelle classe de composés d~imidazopyrazine inhibant une protéine et/ou un checkpoint kinases, des procédés de préparations de tels composés, des compositions pharmaceutiques renfermant un ou plusieurs de ces composés, des procédés de préparation de formulations pharmaceutiques renfermant un ou plusieurs de ces composés et des méthodes de traitement, de prévention, d~inhibition ou d~amélioration d~une ou de plusieurs des maladies associées à la protéine ou au checkpoint kinases, qui utilisent ces composés ou compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyrazines as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyrazines as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrazines as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1530940

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.